Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C E Welander

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
American Journal of Obstetrics and Gynecology|February 1, 1990
Intralesional interferon alfa-2b for the treatment of genital wartsC E Welander, H D Homesley, K A Smiles, et al.
Obstetrics and Gynecology|February 1, 1987
In vitro growth characteristics and chemosensitivities of endometrial cancer using a soft agar clonogenic assayC M Jones, C E Welander, M E Berens, et al.
Obstetrics and Gynecology|October 1, 1975
Factors affecting survival in stage I and state II carcinoma of the cervixC E Welander, G S Montana, W L Saylor, et al.
Obstetrics and Gynecology|May 1, 1997
Placenta previa percreta with bladder invasionW L Leaphart, H Schapiro, J Broome, et al.
Gynecologic Oncology|February 1, 1993
Combined antiproliferative activity of 5-fluorouracil and mitomycin-C against primary human ovarian tumors and cell lines in a clonogenic assayJ Higashihara, M E Berens, L A Collins, et al.
Obstetrics and Gynecology|September 1, 1984
Use of the human tumor stem cell assay to study chemotherapy sensitivity in cancer of the cervixR L Parker, C E Welander, H D Homesley, et al.
American Journal of Obstetrics and Gynecology|March 1, 1992
Laparoscopic radical hysterectomy with paraaortic and pelvic node dissectionC R Nezhat, M O Burrell, F R Nezhat, et al.
International Journal of Cancer|June 15, 1985
Combined recombinant human interferon alpha 2 and cytotoxic agents studied in a clonogenic assayC E Welander, T M Morgan, H D Homesley, et al.
American Journal of Clinical Oncology|April 1, 1989
CA-125 values predictive of clinical response during second-line chemotherapy for epithelial ovarian cancerL W Ng, H D Homesley, R J Barrett, et al.
Cancer|March 1, 1990
The effects of estrogen, progesterone, and tamoxifen alone and in combination with cytotoxic agents against human ovarian carcinoma in vitroK R Geisinger, M E Berens, Y Duckett, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
American Journal of Obstetrics and Gynecology|February 1, 1990
Intralesional interferon alfa-2b for the treatment of genital wartsC E Welander, H D Homesley, K A Smiles, et al.
Obstetrics and Gynecology|February 1, 1987
In vitro growth characteristics and chemosensitivities of endometrial cancer using a soft agar clonogenic assayC M Jones, C E Welander, M E Berens, et al.
Obstetrics and Gynecology|October 1, 1975
Factors affecting survival in stage I and state II carcinoma of the cervixC E Welander, G S Montana, W L Saylor, et al.
Obstetrics and Gynecology|May 1, 1997
Placenta previa percreta with bladder invasionW L Leaphart, H Schapiro, J Broome, et al.
Gynecologic Oncology|February 1, 1993
Combined antiproliferative activity of 5-fluorouracil and mitomycin-C against primary human ovarian tumors and cell lines in a clonogenic assayJ Higashihara, M E Berens, L A Collins, et al.
Obstetrics and Gynecology|September 1, 1984
Use of the human tumor stem cell assay to study chemotherapy sensitivity in cancer of the cervixR L Parker, C E Welander, H D Homesley, et al.
American Journal of Obstetrics and Gynecology|March 1, 1992
Laparoscopic radical hysterectomy with paraaortic and pelvic node dissectionC R Nezhat, M O Burrell, F R Nezhat, et al.
International Journal of Cancer|June 15, 1985
Combined recombinant human interferon alpha 2 and cytotoxic agents studied in a clonogenic assayC E Welander, T M Morgan, H D Homesley, et al.
American Journal of Clinical Oncology|April 1, 1989
CA-125 values predictive of clinical response during second-line chemotherapy for epithelial ovarian cancerL W Ng, H D Homesley, R J Barrett, et al.
Cancer|March 1, 1990
The effects of estrogen, progesterone, and tamoxifen alone and in combination with cytotoxic agents against human ovarian carcinoma in vitroK R Geisinger, M E Berens, Y Duckett, et al.
Pageof 4